• News and Press

The Latest News and Stories Related to the IMS Institute

Global Cancer Drug Spending to Exceed $150 Billion by 2020: IMS Report

02 Jun 2016

Reuters
Worldwide spending on cancer medicines will exceed $150 billion by 2020, driven by the emergence of expensive new therapies that help the immune system to attack tumors, according to a global oncology report released by IMS Health Holdings on Thursday.

The World Spent This Much on Cancer Drugs Last Year

02 Jun 2016

CNBC
Spending on cancer medicines totaled $107 billion worldwide in 2015 and is projected to exceed $150 billion by 2020, reflecting adoption of newer, pricier therapies, according to a report from the IMS Institute for Healthcare Informatics.

We’re spending $107 billion on cancer drugs, but is it worth it?

02 Jun 2016

Washington Post
A flood of innovative cancer treatments helped fuel an 11.5 percent surge in spending on oncology drugs over the past year -- to $107 billion globally, according to a new report. But there's a crucial question the study can't quite answer: How much are patients benefiting from this expanding arsenal of high-priced drugs?

The Ever-Escalating Cost Of Cancer Drugs

02 Jun 2016

CBS MoneyWatch
The total cost of oncology drugs and supportive care medications surged 11.5 percent in 2015 to reach $107 billion globally, according to a new study from IMS Institute for Healthcare Informatics. The spending is based on invoice prices, the amount hospitals or pharmacies paid to distributors.

We're In The Middle Of A Gold Rush In The Cancer-Drug Industry

02 Jun 2016

Business Insider
In the past five years, 70 new cancer treatments have been approved for more than 20 types of tumors.

U.S. Prescription Drug Spending To Hit $400 Billion A Year By 2020: IMS

14 Apr 2016

Reuters
U.S. annual spending on prescription medicines will increase 22 percent over the next five years, climbing as high as $400 billion in 2020, according to a report released by health care information company IMS Health Holdings Inc on Thursday.

Prescription Drug Spending Hits Record $425 Billion in U.S.

14 Apr 2016

Bloomberg
Spending on prescription drugs in the U.S. rose 12 percent to a record $425 billion before discounts last year, boosted in part by the introduction of breakthrough medicines for cancer and the growing number of patients seeking treatment for hepatitis C.

See More

To learn more about ways that the IMS Institute can support your initiatives, please reach out to our team:

 

*Required